Potassium chloride 600mg / Potassium bicarbonate 400mg (total potassium 12mmol) effervescent tablets sugar free
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Potassium bicarbonate + Potassium chloride
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(4)
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
Acute kidney injury: prevention, detection and management (NG148)
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease (MIB12)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 19 studies.
1967–2026
Showing all 19 studies, sorted by most relevant.
F. He, M. Marciniak, C. Carney, et al.
Hypertension, 2010
- Albuminuria
- Bicarbonates
- Blood Pressure
B. Dawson-Hughes, S. Harris, N. Palermo, et al.
The Journal of clinical endocrinology and metabolism, 2009
- Bicarbonates
- Bone Resorption
- Calcium
Kasper Thorsen, V. Dam, K. Kjaer-Sorensen, et al.
Nature Communications, 2017
- Loss of Function Mutation
- Exome Sequencing
- Action Potentials
Abstract Patients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pH i , short QTc, and reduced systolic duration, which is rescued by wildtype but not mutated SLC4A3 . Mechanistic analyses suggest that an increase in pH i and decrease in [Cl − ] i shortened the action potential duration. However, other mechanisms may also play a role. Altered anion transport represents a mechanism for development of arrhythmia and may provide new therapeutic possibilities.
Abstract licence: CC BY
The Journal of Chemical Thermodynamics, 1982
H. Bahamonde, Carlos Pimentel, Luis Lara, et al.
Plants, 2023
Potassium (K) is an essential element, which is often supplied to horticultural crops via foliar spraying. Some studies have investigated the effect of different foliar-applied K compounds; however, most studies have focussed on crop quality and yield parameters, or were performed with isolated leaf cuticles. The aim of this study was to evaluate the rates of the foliar ion penetration and leaf surface deposition of 130 mM K sprays of compounds with markedly different point of deliquescence (POD) and efflorescence (POE) values, the rates having been previously estimated in climate chamber trials. Shoots of field-grown, commercial olive trees were sprayed with K-nitrate (KNO3), K-sulphate (K2SO4), K-chloride (KCl), K-phosphate (K3PO4), K-carbonate (K2CO3) and K-bicarbonate (KHCO3), and leaf samples were collected after 3 and 24 h. Cation and anion concentrations were determined in the leaf tissues, and in a preliminary leaf water wash for estimating surface-deposited ion concentrations. No significant leaf tissue K increments were recorded between the K sprays. Olive tissue anion concentrations showed different patterns, and a chloride (Cl−) increase was detected 3 h after the foliar KCl supply. On the other hand, the foliar K applications led to leaf nitrate changes regardless of the K source supplied. High amounts of K and accompanying ions were recovered in the washing liquid of the foliar K-supplied leaves. Some foliar K treatments increased the leaf surface concentration of sulphate and chloride, suggesting a potential effect on leaf cell anion extrusion. Hence, despite no evidence of foliar K uptake, an effect of leaf anion concentrations was observed, indicating that foliar nutrient sprays may influence leaf and leaf surface anion balance.
Abstract licence: CC BY
Mark Eggertsen, Cecilie Munch Johannsen, Alexander Kovacevic, et al.
Critical Care Medicine, 2023
- Heart Arrest
- Hyperkalemia
- Calcium Chloride
C. Edmonds, J. Marriott
The Journal of endocrinology, 1967
- Adrenalectomy
- Aldosterone
- Bicarbonates
E. Tahaei, T. Pham, Lama Al-Qusairi, et al.
American journal of physiology. Renal physiology, 2023
- Acidosis
- Alkalosis
- Sulfate Transporters
Amanollahi Z, Zaitsau DH, Müller K, et al.
2026
This work aims to develop an approach for the systematic determination of the formation and sublimation enthalpies of inorganic compounds using the examples of potassium bicarbonate, potassium carbonate, and potassium formate. The standard enthalpies of formation in the solid and gas phases are determined using solution calorimetry and the G4 method, respectively, while the enthalpies of sublimation are calculated from lattice energies. Density functional theory (DFT) calculations at the PBE‐D3/projector‐augmented‐wave level are well‐suited to determine sublimation enthalpies based on lattice energies and thus to validate the standard enthalpies of formation of inorganic compounds in the solid and gas phases. The uncertainty associated with the determination of standard formation enthalpies in the solid phase using solution calorimetry is roughly 0.5 kJ·mol −1 , while the uncertainty of sublimation enthalpies from DFT calculations is approximately less than 10 kJ·mol −1 , consistent with recent benchmark studies on representative molecular test sets. Given that the determination of sublimation enthalpies for salts based on vapor pressures is currently not feasible with existing techniques, DFT calculations are a promising approach for determining this quantity. In conclusion, the combination of solution calorimetry and quantum‐chemical calculations offers a consistent framework for determining key thermodynamic properties of inorganic salts.
Abstract licence: CC BY
Sharma S, Khalid A, Herrera GA, et al.
2026
Distal renal tubular acidosis (dRTA) is a rare but recognized renal complication of Sjögren's syndrome (SS), often resulting from autoimmune-mediated damage to acid-base transporters in the distal nephron. It commonly presents with electrolyte abnormalities including hypokalemia and metabolic acidosis. A 47-year-old woman with chronic kidney disease presented with recurrent hypokalemia, mild proteinuria, and sicca symptoms. Workup revealed non-anion gap metabolic acidosis, a positive urine anion gap, and renal potassium wasting consistent with dRTA. Autoimmune testing showed a high-titer ANA (1:1280) and elevated SSA (>8.0), confirming SS. Renal biopsy revealed mild interstitial fibrosis and glomerulosclerosis without evidence of tubulointerstitial nephritis or immune complex deposition. This finding supports prior evidence that SS-associated dRTA may occur secondary to functional tubular defects involving distal nephron transporters, even in the absence of overt inflammatory histologic changes. Acid-base disturbances improved with potassium and bicarbonate supplementation. This case highlights that significant tubular dysfunction in SS may occur despite minimal or absent histologic evidence of tubulointerstitial nephritis. dRTA in SS may result from autoimmune targeting of distal nephron transporters such as H⁺-ATPase and anion exchanger 1. Early recognition and supportive treatment are essential to prevent complications including nephrolithiasis, progressive kidney dysfunction, and life-threatening hypokalemia. SS should be considered in patients presenting with unexplained dRTA, and timely correction of electrolyte abnormalities is critical to optimizing outcomes.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.